Tender Details

Country: Slovakia
Summary: Antineoplastic and Immunomodulatory Agent Description: Part 1 Trastuzumab Deruxtekan Plc Ifc 1X100 Mg (Medad.Inj.Skl. Jantar.)
SKT Ref No: 118308997
Deadline: 28 Apr 2025
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: EUR 505274.70
Notice Type: Tender
Document Ref. No.: 7299 - VST
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
Antineoplastic and immunomodulatory agent Description: Part 1 trastuzumab deruxtekan PLC IFC 1x100 mg (drug.inj.skl. Jantar.) (BT-27-Procedure)(Value): 505 274.70 Expected value (BT-27-Procedure) (currency): Euro main classification type of classification: common vocabulary of procurement Main CPV code: antineoplastic and immunomodulatory agentOrder of the type of classification: joint dictionary of procurement 4.1.5 Information on the point of information on the point of performance of the street: Vojtech Spanyola no. 43 City: Zilina Postal Code: 01207 Nizsia ground unit of the country: Zilinsky region Country: Slovakia 4.2 Information about the procedure 4.2.1 Progress Type: PublicSUMER 4.2.3 Information of the termination of the invitation to the SUMS Termination of the challenge to the SUME: ANO5. Part 5.1 of information on section 5.1.1 Part of the name: antineoplastic and immunomodulatory agent Part no. 1 number: 1 part of the context: antineoplastic and immunomodulatory agent part no. 1 (LOT-0001) SECLEMS OF THE PART REFERENCEName: 109/2024 Names: antineoplastic and immunomodulatory agent Part no. 1 Description: Part 1 trastuzumab deruxtekan PLC IFC 1x100 mg (medicine.inj.sklCPV code: antineoplastic and immunomodulatory agents of information on additional classification of the subject of information about information on additional classification of the subject of the order type of classification: joint dictionary of information procurement of strategic public procurement information about strategic public procurement information information informationon strategic public procurement strategic public procurement: no information about the point of information on the point of fulfillment of the low -country unit of the country: Zilinskycountry country ...
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Antineoplastic and Immunomodulatory Agent Description: Part 1 Trastuzumab Deruxtekan Plc Ifc 1X100 Mg (Medad.Inj.Skl. Jantar.) - Slovakia Tender

The UNIVERSITY HOSPITAL WITH POLYCLINIC ZILINA, a Government sector organization in Slovakia, has announced a new tender for Antineoplastic and Immunomodulatory Agent Description: Part 1 Trastuzumab Deruxtekan Plc Ifc 1X100 Mg (Medad.Inj.Skl. Jantar.). This tender is published on SlovakiaTenders under SKT Ref No: 118308997 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-04-28.

The estimated tender value is EUR 505274.70, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.